Hunan Kelun Pharmaceutical Co., Ltd.
7 clinical trials · Sponsor
◉ Watch Hunan Kelun Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection (NCT07710560) | Hunan Kelun Pharmaceutical Co., Ltd. | 2026-07-15 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers (NCT07474545) | Hunan Kelun Pharmaceutical Co., Ltd. | 2026-03-02 |
| Single-dose,First-in-human of KLA478 (NCT07240675) | Hunan Kelun Pharmaceutical Co., Ltd. | 2025-11-26 |
| A Phase I Study of KLA318-2 Nanocrystal Injection (NCT07171034) | Hunan Kelun Pharmaceutical Co., Ltd. | 2025-09-01 |
| First-in-Human Single and Multiple Dose of KLA578-1 for Injection (NCT07143318) | Hunan Kelun Pharmaceutical Co., Ltd. | 2025-06-05 |
Track Hunan Kelun Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.